Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 15, 2024

BUY
$61.03 - $69.57 $283,362 - $323,013
4,643 New
4,643 $314,000
Q2 2022

Jul 11, 2022

BUY
$59.26 - $71.14 $1.62 Million - $1.95 Million
27,362 Added 455.96%
33,363 $2.24 Million
Q1 2022

Apr 12, 2022

BUY
$55.72 - $67.12 $131,944 - $158,940
2,368 Added 65.18%
6,001 $424,000
Q4 2021

Jan 11, 2022

SELL
$54.02 - $63.83 $972 - $1,148
-18 Reduced 0.49%
3,633 $209,000
Q3 2021

Nov 03, 2021

SELL
$55.56 - $60.79 $111,286 - $121,762
-2,003 Reduced 35.43%
3,651 $221,000
Q2 2021

Jul 14, 2021

BUY
$48.42 - $60.18 $273,766 - $340,257
5,654 New
5,654 $343,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $203B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Brookstone Capital Management Portfolio

Follow Brookstone Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brookstone Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Brookstone Capital Management with notifications on news.